Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.58%||177.12||0.7%||$1156.59m|
|LLY||Eli Lilly & Co.||0.96%||372.06||1.1%||$1068.92m|
|MRK||Merck & Co., Inc.||1.06%||110.08||0.7%||$1002.54m|
|BMY||Bristol-Myers Squibb Co.||0.01%||79.93||1.1%||$742.00m|
|HZNP||Horizon Therapeutics Plc||-0.57%||96.30||5.4%||$286.44m|
|IDXX||IDEXX Laboratories, Inc.||1.13%||420.10||3.9%||$191.38m|
|ALNY||Alnylam Pharmaceuticals, Inc.||5.32%||231.33||8.0%||$168.15m|
|NVO||Novo Nordisk A/S||-0.42%||125.26||0.1%||$152.07m|
GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and is headquartered in San Francisco, California.